Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$145.54 - $178.83 $29.5 Million - $36.2 Million
-202,600 Reduced 88.94%
25,200 $4.37 Million
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $37.7 Million - $45.5 Million
227,800 New
227,800 $38.5 Million
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $5.52 Million - $6.39 Million
34,300 New
34,300 $5.91 Million
Q4 2022

Feb 14, 2023

BUY
$131.14 - $157.47 $550,788 - $661,374
4,200 Added 168.0%
6,700 $982,000
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $370,725 - $456,375
2,500 New
2,500 $371,000
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $62,388 - $80,036
-400 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $77,476 - $98,812
400 New
400 $98,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.